Editorial on

Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder

Santiago Pardo, Gavin Giovannoni, Christopher Hawkes, Jeannette Lechner-Scott, Emmanuelle Waubant, Michael Levy

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)A1-A2
JournalMultiple Sclerosis and Related Disorders
Volume33
DOIs
StatePublished - Aug 1 2019

Fingerprint

Aquaporin 4
Neuromyelitis Optica
eculizumab

Keywords

  • Complement
  • Disease-modifying therapy
  • Eculizumab
  • Neuromyelitis optica spectrum disorder
  • NMO
  • NMOSD

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Editorial on : Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder. / Pardo, Santiago; Giovannoni, Gavin; Hawkes, Christopher; Lechner-Scott, Jeannette; Waubant, Emmanuelle; Levy, Michael.

In: Multiple Sclerosis and Related Disorders, Vol. 33, 01.08.2019, p. A1-A2.

Research output: Contribution to journalEditorial

Pardo, Santiago ; Giovannoni, Gavin ; Hawkes, Christopher ; Lechner-Scott, Jeannette ; Waubant, Emmanuelle ; Levy, Michael. / Editorial on : Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder. In: Multiple Sclerosis and Related Disorders. 2019 ; Vol. 33. pp. A1-A2.
@article{7ab6cc217b534c7a9eb1a113a3d0421d,
title = "Editorial on: Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder",
keywords = "Complement, Disease-modifying therapy, Eculizumab, Neuromyelitis optica spectrum disorder, NMO, NMOSD",
author = "Santiago Pardo and Gavin Giovannoni and Christopher Hawkes and Jeannette Lechner-Scott and Emmanuelle Waubant and Michael Levy",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.msard.2019.07.001",
language = "English (US)",
volume = "33",
pages = "A1--A2",
journal = "Multiple Sclerosis and Related Disorders",
issn = "2211-0348",
publisher = "Elsevier",

}

TY - JOUR

T1 - Editorial on

T2 - Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder

AU - Pardo, Santiago

AU - Giovannoni, Gavin

AU - Hawkes, Christopher

AU - Lechner-Scott, Jeannette

AU - Waubant, Emmanuelle

AU - Levy, Michael

PY - 2019/8/1

Y1 - 2019/8/1

KW - Complement

KW - Disease-modifying therapy

KW - Eculizumab

KW - Neuromyelitis optica spectrum disorder

KW - NMO

KW - NMOSD

UR - http://www.scopus.com/inward/record.url?scp=85068262709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068262709&partnerID=8YFLogxK

U2 - 10.1016/j.msard.2019.07.001

DO - 10.1016/j.msard.2019.07.001

M3 - Editorial

VL - 33

SP - A1-A2

JO - Multiple Sclerosis and Related Disorders

JF - Multiple Sclerosis and Related Disorders

SN - 2211-0348

ER -